For reprint rights or to purchase a copy of your Daily Journal photo, email Jeremy_Ellis@dailyjournal.com for prices or call 213-229-5424.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...
You have to be a subscriber to view this page.

Aug. 6, 2025

Wisner Baum pushes to remand cancer drug case to state court

A breast cancer patient sues major drugmakers for alleged concealment of cancer risks linked to antipsychotics; her attorneys seek to return the case to state court amid procedural delays.

Attorneys from Wisner Baum LLP are fighting to get back to state court to litigate a breast cancer patient's "landmark" negligence and fraud lawsuit against antipsychotic drug makers and retailers over claims they concealed the risk of prolonged exposure to the medications.

The lawsuit, originally filed on April 21 in Alameda County, accuses four companies -- Johnson & Johnson, Eli Lilly and Company, Cheplapharm, and Janssen Pharmaceuticals -- of illegally promot...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.